Efficacy and Safety of Sofosbuvir Plus Ribavirin in Adults With Chronic HCV Infection

NCT02021643 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

687

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic HCV Infection

Interventions

DRUG: Sofosbuvir
DRUG: RBV
DRUG: PEG

Sponsor

Gilead Sciences